PPARG and hepatocellular carcinoma: Although troglitazone and other thiazolidinediones are considered specific PPARγ agonists, several lines of evidence suggest that the growth inhibition of HCC cells induced by high concentrations of troglitazone may occur through PPARγ-independent mechanisms.